摘要
目的：观察肝病患者中血清CRP、AFP、CEA、CA19—9各项指标的含量变化及探讨其在肝病诊断中的价值。方法：采用化学发光法检测AFP、CEA、CA19—9，用免疫透射比浊法检测CRP。结果：原发性肝癌组、肝硬化组、慢性乙肝组中CRP、AFP、CEA、CA19—9含量显著高于正常对照组（P〈0．01）。四项指标联合检测在各组中的阳性率明显高于单一指标的阳性率（P〈0．005）。结论：各指标的检测对判断各种肝病肝损害程度及预后有一定的意义，四项指标联合检测可具有互补作用，可提高各种肝病的诊断率。
objective Observed in patients with liver diseases serum CRP, AFP, CEA, CA19 -9 content in the various indicators and to explore its value in the diagnosis ofliverdisease MethodChemiluminescence was used todetected AFP, CEA, CA19 -9, The CRPdetecthythe immuneturbidimetric. Result Primary liver cancer group, liver cirrhosis, chronic hepatitis B group,CRP,AFP,CEA,CA19 -9 levelsweresignificandy higher than the normal control group （P 〈0. 01 ） ,Joint detection of four targets in each group was significantly higher than that of the positive indicators of the positive rate （P 〈 0.005 ） ConclusionThe detection of the various indicators to judge the extent of liver damage and prognosis of liver disease have a certain significance, the four indicators of joint detection can have a complementary role in the diagnosis of various liver diseases can increase the rate .
关键词
原发性肝癌
慢性乙型肝炎
联合检测
primary carcinoma of the liver
Chronic Hepatitis B
Joint Detection
